Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:341 (9 August), doi:10.1136/bmj.327.7410.341
| The first 150 words of the full text of this article appear below. |
EDITORThe dispiriting BMJ of 31 May uses acres of newsprint to state the obvious that pharmaceutical companies manufacture drugs and promote them to prescribers, who sometimes succumb to the blandishments.1
I have received 53 research grants from 20 sources: research councils, government departments, and medical charities, with one from a pharmaceutical company. I have dealt with industry at many levels, as well as with people from various institutions that support research. All institutions have agendas and special interests, and they are as aware as anyone else of their remit. Many of their agendas are as powerful as or more powerful than those of industry.
Have industry blandishments perverted my clinical practice? A meticulous
search of my desk reveals nine pens, two of which have clear company logos on
them. As an academic I attend academic meetings, usually overseas, at least
once a month. I am certain that on
Simon Wessely, professor of epidemiology and liaison psychiatry
Guy's, King's, and St Thomas's Schools of Medicine, Dentistry, and Biomedical Sciences, London SE1 8WA s.wessely@iop.kcl.ac.uk
Read all Rapid Responses